NKTX•globenewswire•
Nkarta to Participate in Evercore Healthcare Conference
Summary
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the Evercore 8th Annual Healthcare Conference on Thursday in Miami.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 2, 2025 by globenewswire